Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series:

Associate Professor
Holy Spirit University of Kaslik
Project Manager
Karolinska Institutet
Professor
University of Washington
Research Fellow
King's College London
Senior Research Scientist
AstraZeneca
Investigator
GlaxoSmithKline
Professor and Chair of Pharmacology and Personalised Medicine
University of Liverpool
Principal Investigator and Assistant Professor
ICVS and Karolinska Institutet
Professor
Gothenburg University
Professor
University of Edinburgh
Group Leader
Karolinska Institutet
Principal Investigator
University of Trento
Team Leader
Novartis
Cancer Research UK Advanced Clinical Scientist
University of Oxford
Professor and Co-Director
RWTH Aachen University
Principal Investigator
The University of Montpellier
Professor
Technical University Munich
Network Manager Pharmacogenetis & Stratified Medicine
University of Liverpool
Scientist
Genentech
Associate Director
AstraZeneca
Scientific Leader
GlaxoSmithKline
Associate Professor
Radboud Institute for Molecular Life Sciences
Deputy Lab Head
Cancer Research UK
Principal Investigator, Armenise-Harvard Laboratory of Integrative Genomics
The Telethon Institute of Genetics and Medicine
Researcher, Bioinformatics
San Raffaele University
Senior Lecturer in Computational Biology
University of Birmingham
Co-Director of the Genomic Medicine Programme and Lecturer in Bioinformatics
University of Sheffield
Lab Head
Sanofi
Full Professor of Haematology
University of Brescia
Professor
Weizmann Institute of Science
University Medical Center Groningen
Full Professor in Molecular Oncological Pathology and Senior Clinical Scientist in Molecular Patholo
Associate Director of Genomics
Novartis
Professor
Tel Aviv University
UKRI Rutherford Fund Fellow
MRC Weatherall Institute of Molecular Medicine
Associate Professor
University of Copenhagen
Head of DTU Proteomics Core
Technical University Denmark
Professor of Analytical Chemistry and Clinical Chemistry
University of Athens
Director and Senior Researcher
University of Navarra
Research Director
French National Centre for Scientific Research
President and Chief Scientific Officer
Beam Therapeutics
Director
University of Warwick
Senior Director, Head of Computational Biology Oncology R&D
Pfizer
Senior Director
Broad Institute
Senior Lecturer, Analytical Microbiology
University of Surrey
Lab Head professor
German Center for Neurodegenerative Diseases (DZNE) and Life and Medical Sciences Institute, Univers
Bioinformatician
Uppsala University
Bioinformatician
University of Glasgow
Senior Scientist
Editas Medicine
Scientist Computational Biology
Biogen
Instructor Founder and Chief Executive Officer
Harvard University
Team Leader
Wellcome Trust Sanger Institute
Professor of Genetics
University of Oxford
Reader In RNA Biology (Biochemistry)
University of Sussex
Principal Investigator
Princess Máxima Center
Scientific Director
Janssen
Scientific Director, Advances Research
L'Oreal
Associate Professor
Kingston University
Senior Scientist
Merck
Head of Laboratory of Gene Editing and Transgenic Core Facility
Georg Speyer Haus Institute for Tumor Biology and Experimental Therapy
Associate Professor
University of Alicante
Associate Director
AstraZeneca
Executive Director, Personalised Healthcare and Biomarkers
AstraZeneca
Investigator
Novartis
Associate Professor
University of Zurich
Associate Professor
University of Minnesota
Professor of Molecular Genetics
Glasgow University
Director Molecular Tumor Profiling
UniversityHospital Zurich
Professor
University of Verona
Oncode Principal Investigator
Erasmus University Medical Center
Professor of Chemistry
University of North Carolina at Chapel Hill
Professor and Director, Medical Physics and Biophysics
Dana-Farber Cancer Institute
Lead Scientist
Cell and Gene Therapy Catapult
Professor
Inserm
Single Cell Genomics Facility Manager
University of Oxford
Senior Scientist
Roche
Associate Professor
Copenhagen University
Senior Fellow
Northumbria Univrsity
Associate Professor
University of Florence
Senior Expert Genomics
Nestle Research
Research Group Leader
MRC
Arthur J. Schmitt Professor
University of Notre Dame
Lecturer in Healthcare Sciences (Clinical Bioinformatics)
University of Manchester
Head of Imaging and Cytometry
York University
Computational Biologist
GlaxoSmithKline
Principal Investigator
Leiden University Medical Center
Professor of Mechanical Engineering
Columbia University
Research Director
Emendo Biotherapeutics
Researcher
Uppsala University
Professor of Human Genetics
University of Leicester
Senior Principal Scientist, Predictive Sciences
Bristol-Myers Squibb
Assistant Professor
University of California, Irvine
Senior Scientist
GlaxoSmithKline
Director, Reagents and Assay Development, Discovery Sciences
AstraZeneca
Reader and Director of Bioinformatics
Queen Mary University of London
Professor
University of Pittsburgh
Associate Director - CRISPR Safety
AstraZeneca
Professor
Karolinska Institutet
Professor in Molecular Medicine
Trinity College Dublin
Director of Precision Medicine Trials
University of Birmingham
Director of Bioinformatics, Department of Molecular Biology
Massachusetts General Hospital
Head of Genetics
Vanda Pharmaceuticals
Professor
University of Torino
Computational Biologist
GlaxoSmithKline
Senior Research Scientist
Novo Nordisk
Research Fellow, Chair of Hematology
University of Brescia
Investigator
Novartis
Research Director and Professor
Technical University of Denmark
Data Scientist, Group Leader
Brandenburg University
Team Leader and Researcher
SciLifeLab and Royal Institute of Technology
Professor in Molecular Genetics
University College London
Associate Professor, Molecular Therapy
University of Oxford
Senior Professor
Karolinska Institute
Associate Professor in Cellular and Molecular Sciences
Northumbria University
Professor
University of Geneva
Reader in Immunogenetics
University of Southampton
Professor and Director, Institute for Transfusion Medicine and Gene Therapy
University of Freiburg
Professor, Dept. of Microbiology, Tumour and Cell Biology
Karolinska Institute
Lead Technical Scientist
Cell and Gene Therapy Catapult
Professor
Uppsala University
Principal Scientist/Team Leader
Artios Pharma Ltd
Assistant Professor
University of Ghent
Chief Operation Officer
Erasmus MC
Group Leader and Assistant Professor
Uppsala University
Computational Immunologist
Janssen
Professor and Director
Juntendo University
Principal Scientist | Computational Genomics
Bristol-Myers Squibb
Senior Scientist
Biogen
Professor
Simon Fraser University

Live Webinar

Genomic Testing Strategies For Research Through To Clinical Studies: Profiling Of Genomics From NeoGenomics' Perspective

As genomic technologies develop and mature, adoption moves from the research environment into the clinical setting.  Previously, where Sanger and qPCR were the most rational choices to commercialize a diagnostic, NGS has become the biomarker testing methodology of choice.  Additionally, other emerging technologies and platforms like NanoString are finding their way into clinical trials as well as routine diagnostics.  With advances in technology, biomarker testing strategies have also evolved with a trend toward higher order multiplexed technologies as well as cross modality testing from a single sample to understand correlations between DNA, RNA and protein markers.  More data may be over burdensome to analyze, while a focused assay may miss an opportunity for collecting potentially valuable data.  Without a straightforward “rule of thumb” for which genomics technology to use when, thoughtful consultation is required.  This presentation will discuss the various factors and consideration points for choosing a genomic biomarker testing strategy to support biomarker projects.

Presented by James Yen, Senior Scientific Manager, CDx Programs, NeoGenomics

Thursday, 25 June 2020 | 15:30 BST